|
|
This screen finds stocks with a 13-week Relative Strength above 70, meaning their price gain over the last 13 weeks ranks in the top 30% of all stocks on the same exchange, which marks them as stocks clearly beating most of the market. Relative Strength is a percentile ranking: a reading of 70 means the stock outperformed 70% of its peers. This is a quarterly ranking that identifies intermediate-term leaders, a common focus of momentum strategies. Do not confuse it with the RSI oscillator.
|
|
|
| Symbol | Name | Industry | Sector | 1-Week Relative Strength | 2-Week Relative Strength | 4-Week Relative Strength | 13-Week Relative Strength | 26-Week Relative Strength | 52-Week Relative Strength | Last | Volume |
| |
| Diagnostics & Research | Healthcare | 80 /100 | 56 /100 | 54 /100 | 90 /100 | 90 /100 | 34 /100 | 70.34 |
403,470 |
| |
| Diagnostics & Research | Healthcare | 73 /100 | 68 /100 | 51 /100 | 80 /100 | 87 /100 | 63 /100 | 18.10 |
1,691,423 |
| |
| Diagnostics & Research | Healthcare | 8 /100 | 14 /100 | 13 /100 | 84 /100 | 98 /100 | 99 /100 | 21.18 |
139,273 |
| |
| Diagnostics & Research | Healthcare | 84 /100 | 39 /100 | 37 /100 | 96 /100 | 93 /100 | 89 /100 | 33.08 |
202,877 |
| |
| Diagnostics & Research | Healthcare | 75 /100 | 29 /100 | 36 /100 | 76 /100 | 90 /100 | 33 /100 | 20.10 |
239,565 |
| |
| Diagnostics & Research | Healthcare | 91 /100 | 98 /100 | 60 /100 | 96 /100 | 93 /100 | 62 /100 | 1.63 |
1,800,258 |
| |
| Diagnostics & Research | Healthcare | 74 /100 | 55 /100 | 42 /100 | 92 /100 | 99 /100 | 96 /100 | 15.85 |
1,115,838 |
| |
| Diagnostics & Research | Healthcare | 11 /100 | 10 /100 | 9 /100 | 92 /100 | 15 /100 | 76 /100 | 11.82 |
51,515 |
| |
| Diagnostics & Research | Healthcare | 15 /100 | 19 /100 | 21 /100 | 98 /100 | 99 /100 | 22 /100 | 7.27 |
222,762 |
| |
| Drug Manufacturers - General | Healthcare | 51 /100 | 81 /100 | 89 /100 | 90 /100 | 97 /100 | 85 /100 | 285.64 |
4,597,448 |
| |
| Drug Manufacturers - General | Healthcare | 76 /100 | 90 /100 | 92 /100 | 92 /100 | 92 /100 | 92 /100 | 439.26 |
1,676,719 |
| |
| Drug Manufacturers - General | Healthcare | 88 /100 | 91 /100 | 81 /100 | 81 /100 | 24 /100 | 48 /100 | 171.49 |
3,666,257 |
| |
| Drug Manufacturers - General | Healthcare | 86 /100 | 63 /100 | 33 /100 | 84 /100 | 89 /100 | 90 /100 | 263.81 |
5,308,118 |
| |
| Drug Manufacturers - General | Healthcare | 73 /100 | 92 /100 | 88 /100 | 89 /100 | 97 /100 | 94 /100 | 1,273.46 |
2,266,275 |
| |
| Drug Manufacturers - General | Healthcare | 37 /100 | 51 /100 | 37 /100 | 93 /100 | 94 /100 | 96 /100 | 145.27 |
8,377,849 |
| |
| Drug Manufacturers - General | Healthcare | 92 /100 | 95 /100 | 93 /100 | 94 /100 | 94 /100 | 95 /100 | 250.69 |
1,130,953 |
| |
| Drug Manufacturers - General | Healthcare | 85 /100 | 81 /100 | 64 /100 | 77 /100 | 76 /100 | 92 /100 | 61.48 |
9,731,593 |
| |
| Drug Manufacturers - General | Healthcare | 50 /100 | 84 /100 | 87 /100 | 91 /100 | 89 /100 | 86 /100 | 156.04 |
6,062,136 |
| |
| Drug Manufacturers - General | Healthcare | 83 /100 | 93 /100 | 73 /100 | 71 /100 | 31 /100 | 76 /100 | 50.75 |
3,161,742 |
| |
| Drug Manufacturers - General | Healthcare | 76 /100 | 88 /100 | 84 /100 | 95 /100 | 88 /100 | 86 /100 | 30.03 |
29,374,930 |
| |
| Drug Manufacturers - General | Healthcare | 94 /100 | 58 /100 | 69 /100 | 90 /100 | 44 /100 | 18 /100 | 3.49 |
35,236 |
| |
| Drug Manufacturers - Specialty & Generic | Healthcare | 75 /100 | 95 /100 | 94 /100 | 78 /100 | 79 /100 | 69 /100 | 10.27 |
15,066,421 |
| |
| Drug Manufacturers - Specialty & Generic | Healthcare | 70 /100 | 87 /100 | 87 /100 | 83 /100 | 37 /100 | 19 /100 | 13.21 |
3,909,234 |
| |
| Drug Manufacturers - Specialty & Generic | Healthcare | 85 /100 | 92 /100 | 90 /100 | 93 /100 | 91 /100 | 91 /100 | 20.24 |
2,099,176 |
| 3396 matches |
|
|
Data as of Oct 23, 2026, updated intraday
|
|
|
|
| |